3D細胞培養の世界市場の評価：タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界の3D細胞培養の市場規模は、2023年の13億8,000万米ドルから2031年に33億1,000万米ドルに達すると予測され、2024年～2031年の予測期間にCAGRで11.61%の成長が見込まれます。

3D細胞培養市場の主な促進要因は、3Dモデルの精度と信頼性を高める技術の進歩、研究開発による資金調達の改善、個別化医療に対する需要の増加です。また、特に動物モデルへの依存を減らすための代替検査法へのシフトや、臓器移植や組織工学のニーズの高まりもあります。戦略的パートナーシップや共同研究は、技術革新や新技術へのアクセス向上を通じて市場成長につながります。

3D細胞培養は先駆的な細胞培養技術の1つであり、細胞を生体組織における本来の構造に近い状態で増殖させることができます。従来の2D培養とは異なり、3D細胞培養は、生体内条件に似た細胞の挙動、成長、相互作用についてより深い見識を提供します。この技術は、治療に対するヒトの反応を予測できることから、創薬、腫瘍学研究、再生治療において有望な位置を占めています。バイオ技術革新の進行に加え、より生理学的に関連性の高いモデルに対する需要の高まりが、3D細胞培養市場の急速な拡大につながっており、ライフサイエンス領域において極めて重要なものとなっています。

例えば2024年4月、Sartorius AGはTheWell Bioscience Inc.と提携し、3D細胞モデルの創薬ワークフロー向けのハイドロゲルおよびバイオインクソリューションを開発しました。Sartoriusのラボ部門も、TheWell Bioscienceの製品の流通と少規模株主への投資を通じて強化される予定です。同社は、オルガノイドモデルにおいて、動物由来のモデルからヒトに関連したモデルへの改良を促進し、創薬におけるよりよい予測を可能にすることを目指しています。この相乗効果により、TheWell Bioscienceの細胞イメージング生物分析ラボ器具およびソリューションで市場成長がさらに加速し、Sartoriusの革新的な優位性が強化されます。

当レポートでは、世界の3D細胞培養市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の3D細胞培養市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別
  • 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
• 市場マップ分析（2023年）
  • タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第5章 北米の3D細胞培養市場の見通し（2017年～2031年）

• 市場規模の分析と予測
  • 金額
• 市場シェアの分析と予測
  • タイプ別
  • 用途別
  • エンドユーザー別
  • シェア：国別
• 各国の市場の評価
  • 米国の3D細胞培養市場の見通し（2017年～2031年）
  • カナダ
  • メキシコ

第6章 欧州の3D細胞培養市場の見通し（2017年～2031年）

• ドイツ
• フランス
• イタリア
• 英国
• ロシア
• オランダ
• スペイン
• トルコ
• ポーランド

第7章 アジア太平洋の3D細胞培養市場の見通し（2017年～2031年）

• インド
• 中国
• 日本
• オーストラリア
• ベトナム
• 韓国
• インドネシア
• フィリピン

第8章 南米の3D細胞培養市場の見通し（2017年～2031年）

• ブラジル
• アルゼンチン

第9章 中東・アフリカの3D細胞培養市場の見通し（2017年～2031年）

• サウジアラビア
• アラブ首長国連邦
• 南アフリカ

第10章 需給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

• 市場促進要因
• 市場の課題

第16章 市場の動向と発展

第17章 規制枠組みとイノベーション

• 規制当局の承認

第18章 ケーススタディ

第19章 競合情勢

• マーケットリーダー上位5社の競合マトリクス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Thermo Fisher Scientific, Inc.
  • InSphero AG
  • Sartorius AG
  • Merck KGaA
  • Becton, Dickinson And Company.
  • CN Bio Innovations Ltd
  • Lonza Group Ltd.
  • Corning Incorporated
  • Lena Biosciences
  • CytoNest, Inc.

第20章 戦略的推奨

第21章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 2. Global 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 3. Global 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 4. Global 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 5. Global 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 6. Global 3D Cell Culture Market Share (%), By Region, 2017-2031F
• Figure 7. North America 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 8. North America 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 9. North America 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 10. North America 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 11. North America 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 12. North America 3D Cell Culture Market Share (%), By Country, 2017-2031F
• Figure 13. United States 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 14. United States 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 15. United States 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 16. United States 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 17. United States 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 19. Canada 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 20. Canada 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 21. Canada 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 22. Canada 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 24. Mexico 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 25. Mexico 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 26. Mexico 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 27. Mexico 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 29. Europe 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 30. Europe 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 31. Europe 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 32. Europe 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe 3D Cell Culture Market Share (%), By Country, 2017-2031F
• Figure 34. Germany 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 35. Germany 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 36. Germany 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 37. Germany 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 38. Germany 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 39. France 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 40. France 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 41. France 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 42. France 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 43. France 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 45. Italy 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 46. Italy 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 47. Italy 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 48. Italy 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 50. United Kingdom 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 51. United Kingdom 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 52. United Kingdom 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 53. United Kingdom 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 55. Russia 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 56. Russia 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 57. Russia 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 58. Russia 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 60. Netherlands 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 61. Netherlands 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 62. Netherlands 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 63. Netherlands 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 65. Spain 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 66. Spain 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 67. Spain 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 68. Spain 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 70. Turkey 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 71. Turkey 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 72. Turkey 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 73. Turkey 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 75. Poland 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 76. Poland 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 77. Poland 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 78. Poland 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 79. South America 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 80. South America 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 81. South America 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 82. South America 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 83. South America 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 84. South America 3D Cell Culture Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 86. Brazil 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 87. Brazil 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 88. Brazil 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 89. Brazil 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 91. Argentina 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 92. Argentina 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 93. Argentina 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 94. Argentina 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 96. Asia-Pacific 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 97. Asia-Pacific 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 98. Asia-Pacific 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 99. Asia-Pacific 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific 3D Cell Culture Market Share (%), By Country, 2017-2031F
• Figure 101. India 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 102. India 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 103. India 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 104. India 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 105. India 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 106. China 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 107. China 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 108. China 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 109. China 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 110. China 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 112. Japan 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 113. Japan 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 114. Japan 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 115. Japan 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 117. Australia 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 118. Australia 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 119. Australia 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 120. Australia 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 122. Vietnam 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 123. Vietnam 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 124. Vietnam 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 125. Vietnam 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 127. South Korea 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 128. South Korea 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 129. South Korea 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 130. South Korea 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 132. Indonesia 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 133. Indonesia 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 134. Indonesia 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 135. Indonesia 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 137. Philippines 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 138. Philippines 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 139. Philippines 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 140. Philippines 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 142. Middle East & Africa 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 143. Middle East & Africa 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 144. Middle East & Africa 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 145. Middle East & Africa 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa 3D Cell Culture Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 148. Saudi Arabia 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 149. Saudi Arabia 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 150. Saudi Arabia 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 151. Saudi Arabia 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 153. UAE 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 154. UAE 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 155. UAE 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 156. UAE 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa 3D Cell Culture Market, By Value, in USD Billion, 2017-2031F
• Figure 158. South Africa 3D Cell Culture Market, By Volume, in Units, 2017-2031F
• Figure 159. South Africa 3D Cell Culture Market Share (%), By Type, 2017-2031F
• Figure 160. South Africa 3D Cell Culture Market Share (%), By Application, 2017-2031F
• Figure 161. South Africa 3D Cell Culture Market Share (%), By End-user, 2017-2031F
• Figure 162. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global 3D cell culture market is projected to witness a CAGR of 11.61% during the forecast period 2024-2031, growing from USD 1.38 billion in 2023 to USD 3.31 billion in 2031.

The several key drivers of the 3D cell culture market are the advancement in the technologies that increase the accuracy and reliability of 3D models, improved funding through research and development, and an increasing demand for personalized medicine. Also, there is a shift toward alternative testing methods, especially to reduce animal model dependencies and the rising need for organ transplantation and tissue engineering. Strategic partnerships and collaborations lead to market growth through innovation and increased access to the latest technologies.

3D cell culture is one of the pioneering cell culture techniques that allows cells to grow in a condition more reminiscent of their native structures in living tissues. Unlike traditional 2D cultures, 3D cell cultures provide deeper insight into cell behavior, growth, and interactions, resembling in-vivo conditions. The technique holds a promising position in drug discovery, oncological research, and regenerative therapy as it provides predictability of human responses to treatments. Increasing demand for more physiologically relevant models combined with advances in biotechnological innovations has led to quick expansion in the 3D cell culture market, making it crucial in the life sciences domain.

For instance, in April 2024, Sartorius AG partnered with TheWell Bioscience Inc. to develop hydrogel and bioink solutions for drug discovery workflows of 3D cell models. Sartorius' lab division is also going to be strengthened through the distribution of TheWell Bioscience's products and investment in a minority shareholding. The company aims to facilitate improvement from a model based on animal sources to one that is human-relevant in the organoid models, thereby allowing better predictions in drug discovery. This synergy will further accelerate market growth with TheWell Bioscience's cell imaging bioanalytical lab instruments and solutions to reinforce Sartorius' innovative edge.

Expanding Role of 3D Cell Culture

The growing roles of the 3D cell culture market are largely propelling its growth. Pharmaceutical and biotech companies are increasingly employing such cultures in drug discovery and development, having found them to be more predictive of human responses than conventional models. Advanced research into tissue engineering and regenerative medicine by academic institutions also enhances market growth by incorporating 3D cell cultures. The increased ethical scrutiny of experiments, such that results can be accomplished with 3D cell models rather than involving animals, is driving the market increase. These expanded applications, along with efficiencies of collaboration between different sectors, have inspired innovation and expanded the 3D cell cultures to broaden research and clinical applications.

For instance, PHC Holdings Corporation's Biomedical Division launched LiCellMo, a live cell metabolic analyzer, in Japan and North America in September and October 2024, respectively. This allows researchers to observe real-time changes in metabolism in culture. The goal is to attain a panoramic view of the activity for potential applications in cell and gene therapies (CGT) research. The device uses PHC's proprietary high-precision in-line monitoring technology that allows continuous measurement of cellular metabolites in a culture medium without disrupting experiments.

Advancements in 3D Cell Culture Techniques Drive Market Growth

Advancements in 3D cell culture technologies, especially microfluidics, have transformed market growth. High accuracy and scalability of cell models through a controlled flow of nutrients, oxygen, and waste in a microfluidic system that closely mimics physiological conditions in real-time. This technique supports the creation of highly accurate tissue and organ models, which are ideal for testing drug toxicity and applications of personalized medicine. By allowing high-throughput screening and reducing reagent usage, microfluidics lowers operational costs and improves experimental reproducibility, attracting significant investment and research interest. As a result, microfluidics is expanding the applications and value of 3D cell culture systems. For instance, in September 2024, InSphero Inc. entered into a distribution agreement with Darwin Microfluidics to expand the reach of their 3D in vitro products in the European Union. InSphero products will be easily accessible to EU researchers because of its partnership with Darwin Microfluidics, a startup developing advanced microfluidic solutions. This deal reflects the fast uptake of microfluidics and technological advancement in the market, increasing growth and innovation in 3D cell culture applications.

Investment in Research Fueling the Market Growth

Strategic investments into the 3D cell culture market have expanded its growth as it encourages innovation and technology development. More venture capital and research grants are being allocated to support the establishment of complex 3D models that are more accurate than conventional 2D cultures with enhanced predictive values. Investments of this nature are accelerating partnerships and collaborations among companies, academics, and research organizations, further accelerating the commercialization of new technologies. In addition to this, strategic investments have increased fields of applications for 3D cell cultures in drug discovery, regenerative medicine, and personalized therapy. Similarly, financial investment enhances manufacturing capacity and scale-up ability to make 3D cell cultures available for research and clinics. Thus, strategic investments help to build up the market by making 3D cell cultures innovate and expanding their utility.

For instance, in September 2024, Carl Zeiss AG invested strategically in the life science startup InSphero AG to accelerate innovation in 3D cell culture research. InSphero AG focuses on the development of 3D spheroid and cell-based assays for pharmaceutical drug discovery and safety testing. The received funding will be used to commercialize its cryo-preservation technology and further speed up the growth and scalability of the company. This funding was shared between internal and external investors, including ZEISS Ventures.

Dominance of Scaffold-Based Type in 3D Cell Culture

The scaffold-based segment dominated the market of 3D cell culture mainly because it can closely mimic the natural extracellular matrix and provides a more realistic environment for cells to grow. This stimulates cell-cell and cell-matrix interactions, thus ensuring better cell differentiation as well as functionality. Scaffold-based systems play an important role in establishing intricate tissue patterns, which are crucial for advanced drug testing as well as regenerative medicine applications. These also keep longer-term cultures and resemble the vivo environment more closely than traditional 2D cultures. These features make scaffold-based models more valuable for research and clinical applications, giving them a major market share. The preference to use scaffold-based 3D cell cultures over others by researchers shows the importance of these types in getting more accurate experimental and reliable results.

For instance, in August 2024, CytoNest Inc., a University of Georgia startup, launched its first commercial product, the CytoSurge 3D fiber scaffold. This is a next-generation system in cell manufacturing and tissue engineering and supports applications in cell research, biopharmaceuticals, cell therapies, and cultured meat and seafood. Advanced scaffolding technologies, such as new developments in the CytoSurge 3D fiber scaffold, drive market growth based on optimization through various applications in research and industrial use.

North America Dominates 3D Cell Culture Market Share

North America dominates the global 3D cell culture market due to high R&D investments in the region, well-established biotechnology and pharmaceutical infrastructure, and a strong regulatory framework that supports advanced research. Many world-leading biopharma companies are headquartered in the US, and their research institutions are very much actively involved in stem cell research, cancer biology, and regenerative medicine, where 3D cell cultures are important. Strong government funding is another driving force for innovation in the region, especially from bodies such as the NIH. Due to the biopharmaceutical hub in the region, there is access to advanced technologies that drive the rapid adoption and integration of 3D cell culture techniques into biomedical research.

In July 2023, 3D BioFibR Inc. raised over USD 3.2 million in seed financing. Funds that will be utilized in capacity expansion efforts via climate-controlled biomanufacturing and bringing high-quality collagen fiber products to market. Such products offer an excellent prospect for use in 3D cell culture and tissue engineering applications. This momentum is expected to be realized in North America as companies line up their upgraded capabilities within the region to propel growth in the market further.

Future Market Scenario (2024-2031F)

Advancements in technology coupled with an increasing number of applications for drug discovery, personalized medicine, and regenerative therapies would define the outlook of this market over the near future. Improved modeling capabilities, responsible research practices, and increased collaborations will likely fuel growth in this market, making 3D cell cultures an essential tool for new biomedical research and clinical developments.

Moreover, company expansions boost market growth due to improved manufacturing capacity and increased access to cutting-edge technologies. In July 2023, the company Inventia Life Science Pty Ltd. expanded its operations to India through a partnership with Biotron Healthcare PVT Ltd. to distribute RASTRUM. By making possible cancer, neurodegenerative disease, and fibrotic condition research through advanced cellular models, RASTRUM serves as a backbone in drug discovery, disease modeling, and basic biological research by focusing on physiologically meaningful models of disease.

Key Players Landscape and Outlook

Prominent players in the 3D cell culture market drive growth through strategic partnerships, new product launches, and expansion of the distribution network. Such strategies help enhance market presence, stimulate innovation, and provide greater access to leading-edge cell culture technologies.

In August 2023, InSphero AG collaborated with Advanced BioMatrix, Inc., an industry leader in 3D life science applications to expand the scope of applications in 3D cell culture into scaffold-based models. Under this partnership, InSphero's Akura Plate Technology will be distributed by Advanced BioMatrix in the U.S. It will enhance its market penetration and strengthen its position in this market.

In August 2023, Sartorius AG launched an integrated bioreactor system in collaboration with Repligen Corporation that enables customers to integrate Repligen's XCell ATF upstream intensification technology with Sartorius' Biostat STR bioreactor. The innovation simplifies intensified seed train and N perfusion processes for biopharmaceutical manufacturers. This launch further highlights the market leadership position of Sartorius in process intensification and upstream processing technologies and strengthens its overall market position.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global 3D Cell Culture Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Type
    • 4.2.1.1. Scaffold-based
      • 4.2.1.1.1. Hydrogels-Based Scaffolds
      • 4.2.1.1.2. Polymeric and Natural Scaffolds
      • 4.2.1.1.3. Micropatterned Surface Scaffolds
      • 4.2.1.1.4. Solid Scaffolds
    • 4.2.1.2. Scaffold-free
      • 4.2.1.2.1. Hanging Drop Microplates
      • 4.2.1.2.2. Spheroid Microplates with ULA coating
      • 4.2.1.2.3. Magnetic Levitation and 3D Bioprinting
      • 4.2.1.2.4. 3D Petri Dishes
      • 4.2.1.2.5. 3D Bioreactors
      • 4.2.1.2.6. Microfluidic 3D Cell Culture
  • 4.2.2. By Application
    • 4.2.2.1. Cancer Research
    • 4.2.2.2. Stem Cell Research and Tissue Engineering
    • 4.2.2.3. Drug Development and Toxicity Testing
    • 4.2.2.4. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Biotechnology and Pharmaceutical Companies
    • 4.2.3.2. Academic and Research Institutes
    • 4.2.3.3. Hospitals
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia-Pacific
    • 4.2.4.4. South America
    • 4.2.4.5. Middle East and Africa
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Type
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. North America 3D Cell Culture Market Outlook, 2017-2031F*

• 5.1. Market Size Analysis & Forecast
  • 5.1.1. By Value
• 5.2. Market Share Analysis & Forecast
  • 5.2.1. By Type
    • 5.2.1.1. Scaffold-Based
      • 5.2.1.1.1. Hydrogels-Based Scaffolds
      • 5.2.1.1.2. Polymeric and Natural Scaffolds
      • 5.2.1.1.3. Micropatterned Surface Scaffolds
      • 5.2.1.1.4. Solid Scaffolds
    • 5.2.1.2. Scaffold-Free
      • 5.2.1.2.1. Hanging Drop Microplates
      • 5.2.1.2.2. Spheroid Microplates with ULA coating
      • 5.2.1.2.3. Magnetic Levitation and 3D Bioprinting
      • 5.2.1.2.4. 3D Petri Dishes
      • 5.2.1.2.5. 3D Bioreactors
      • 5.2.1.2.6. Microfluidic 3D Cell Culture
  • 5.2.2. By Application
    • 5.2.2.1. Cancer Research
    • 5.2.2.2. Stem Cell Research and Tissue Engineering
    • 5.2.2.3. Drug Development and Toxicity Testing
    • 5.2.2.4. Others
  • 5.2.3. By End-user
    • 5.2.3.1. Biotechnology and Pharmaceutical Companies
    • 5.2.3.2. Academic and Research Institutes
    • 5.2.3.3. Hospitals
    • 5.2.3.4. Others
  • 5.2.4. By Country Share
    • 5.2.4.1. United States
    • 5.2.4.2. Canada
    • 5.2.4.3. Mexico
• 5.3. Country Market Assessment
  • 5.3.1. United States 3D Cell Culture Market Outlook, 2017-2031F*
    • 5.3.1.1. Market Size Analysis & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share Analysis & Forecast
      • 5.3.1.2.1. By Type
        • 5.3.1.2.1.1. Scaffold-based
        • 5.3.1.2.1.1.1. Hydrogels-based Scaffolds
        • 5.3.1.2.1.1.2. Polymeric and Natural Scaffolds
        • 5.3.1.2.1.1.3. Micropatterned Surface Scaffolds
        • 5.3.1.2.1.1.4. Solid Scaffolds
        • 5.3.1.2.1.2. Scaffold-free
        • 5.3.1.2.1.2.1. Hanging Drop Microplates
        • 5.3.1.2.1.2.2. Spheroid Microplates with ULA coating
        • 5.3.1.2.1.2.3. Magnetic Levitation & 3D Bioprinting
        • 5.3.1.2.1.2.4. 3D Petri Dishes
        • 5.3.1.2.1.2.5. 3D Bioreactors
        • 5.3.1.2.1.2.6. Microfluidic 3D Cell Culture
      • 5.3.1.2.2. By Application
        • 5.3.1.2.2.1. Cancer Research
        • 5.3.1.2.2.2. Stem Cell Research and Tissue Engineering
        • 5.3.1.2.2.3. Drug Development and Toxicity Testing
        • 5.3.1.2.2.4. Others
      • 5.3.1.2.3. By End-user
        • 5.3.1.2.3.1. Biotechnology and Pharmaceutical Companies
        • 5.3.1.2.3.2. Academic and Research Institutes
        • 5.3.1.2.3.3. Hospitals
        • 5.3.1.2.3.4. Others
  • 5.3.2. Canada
  • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe 3D Cell Culture Market Outlook, 2017-2031F

• 6.1. Germany
• 6.2. France
• 6.3. Italy
• 6.4. United Kingdom
• 6.5. Russia
• 6.6. Netherlands
• 6.7. Spain
• 6.8. Turkey
• 6.9. Poland

7. Asia-Pacific 3D Cell Culture Market Outlook, 2017-2031F

• 7.1. India
• 7.2. China
• 7.3. Japan
• 7.4. Australia
• 7.5. Vietnam
• 7.6. South Korea
• 7.7. Indonesia
• 7.8. Philippines

8. South America 3D Cell Culture Market Outlook, 2017-2031F

• 8.1. Brazil
• 8.2. Argentina

9. Middle East and Africa 3D Cell Culture Market Outlook, 2017-2031F

• 9.1. Saudi Arabia
• 9.2. UAE
• 9.3. South Africa

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

• 15.1. Market Drivers
• 15.2. Market Challenges

16. Market Trends and Developments

17. Regulatory Framework and Innovation

• 17.1. Regulatory Approvals

18. Case Studies

19. Competitive Landscape

• 19.1. Competition Matrix of Top 5 Market Leaders
• 19.2. SWOT Analysis for Top 5 Players
• 19.3. Key Players Landscape for Top 10 Market Players
  • 19.3.1. Thermo Fisher Scientific, Inc.
    • 19.3.1.1. Company Details
    • 19.3.1.2. Key Management Personnel
    • 19.3.1.3. Products and Services
    • 19.3.1.4. Financials (As Reported)
    • 19.3.1.5. Key Market Focus and Geographical Presence
    • 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 19.3.2. InSphero AG
  • 19.3.3. Sartorius AG
  • 19.3.4. Merck KGaA
  • 19.3.5. Becton, Dickinson And Company.
  • 19.3.6. CN Bio Innovations Ltd
  • 19.3.7. Lonza Group Ltd.
  • 19.3.8. Corning Incorporated
  • 19.3.9. Lena Biosciences
  • 19.3.10. CytoNest, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

20. Strategic Recommendations

21. About Us and Disclaimer